Tech Company Financing Transactions

Trellis Bioscience Funding Round

Easton Capital, Morgenthaler Ventures and Novartis BioVenture Fund joined a $10 million funding round for Trellis Bioscience. This venture round was announced on 12/31/2007.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

845 Oak Grove Ave. 202
Menlo Park, CA 94025
USA

Phone

(650) 838-1400

Website

www.trellisbio.com

Email Address

Not Recorded

Overview

Trellis Bioscience, Inc. has developed a breakthrough technology platform for discovery and selection of very rare cells that produce ideal proteins such as antibodies, selected for specificity, selectivity, affinity, secretion rate and other desired characteristics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stefan Ryser

        

Chief Marketing Officer

Anton Leighton

        

Chief Technical Officer

Stote Ellsworth

        

Founder

Lawrence Kauvar

        

VP - R & D

Mikhail Gishizky

        

Browse more venture capital transactions:

Prev: 12/31/2007: SIMtone venture capital transaction
Next: 12/31/2007: Vorago Technologies venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary